```
REGISTERED COMPANY NUMBER: 01676618 (England and Wales)
REGISTERED CHARITY NUMBER: 286197
```

```
Report of the Trustees and
```

```
Unaudited Financial Statements for the Year Ended 31 December 2022
```

```
for
```

```
British Toxicology Society(The)
```

```
Sutton McGrath Hartley
5 Westbrook Court
Sharrowvale Road
Sheffield
South Yorkshire
S11 8YZ
```



```
British Toxicology Society(The)
```

## `Contents of the Financial Statements for the Year Ended 31 December 2022` 

||**`Page`**|
|---|---|
|**`President's Report`**|`1 to 2`|
|**`Report of the Trustees`**|`3 to 4`|
|**`Independent Examiner's Report`**|`5`|
|**`Statement of Financial Activities`**|`6`|
|**`Balance Sheet`**|`7 to 8`|
|**`Notes to the Financial Statements`**|`9 to 15`|
|**`Detailed Statement of Financial Activities`**|`16 to 18`|





```
British Toxicology Society(The)
```

## `President's Report for the Year Ended 31 December 2022` 

```
As of the date of this report,I am now comingto the end of my first of two years as BTS President.It has been a great
privilegetoactasyourPresidentduringthistime.ThecurrentsuccessoftheSocietyisduetotheexcellent efforts
frommanyindividualswhogenerouslygiveuptheirtimeto serve onvariousBTS Committees.Withouttheefforts of
the various BTS committee members the Society would not be able to function.
```

```
The last year has seen some returnto normalityafter the issues of the Covid pandemic.We held a very successful face
to face AnnualCongress meeting in Newcastle in April 2022, which was attendedby over 220 delegates.I do hope that
the2023BTSCongressinBirminghamwillbeevenmoresuccessfulinattractingBTSmemberstoparticipatein the
meeting.
```

```
Forthe2023CongressIshouldliketooffermycongratulationstothethreeawardwinnerswhowill make
presentationsatthemeeting.The2023BarnesPrizewinnerisProfessorSamuelCohen(Universityof Nebraska
MedicalCenter,USA),theMalcolmBlackwellAwardwinnerisProfessorMatthewWright(Universityof Newcastle)
andthe FrankSullivanEarlyCareerAwardwinneris Dr LizaEmirali(MRC ToxicologyUnit,Universityof Cambridge). In
addition,a new BTS award,namelythePresident'sAward,willbe presentedforthefirsttimethisyear.Thisaward is
to recognisea BTS member who has made a significantcontributionto the Society.I am please to informyou that the
2023President'sAwardwinnerisJuliannaBerrie(OfficeforProductSafetyandStandards).Fulldetailsofallthe BTS
awards are available on the website.
```

```
In terms of BTS membership,we have seen some increasein BTS membershipin 2022 comparedto 2020 and 2021. As
oftheendofDecember2022,wehadatotalof874members,ofwhichfull,student,postgraduateandearly career
members comprised 496, 183, 56 and 81 members, respectively.
```

```
BTSincomeisderivedfromtwomainsources,namelydonationsandmembershipsubscriptions.Withrespect to
donations,IshouldliketoacknowledgewiththanksfinancialsupportfromApconiX,AstraZeneca, GlaxoSmithKline,
SyngentaandUnilever.Inaddition,somecompaniesprovideddonationstohelpfinancethe2022Annual Congress.
These companiesincludedApconiX,Cyprotex,NC3Rs,RegulatoryScienceAssociates,SequaniandUCB. I wouldask all
BTS members to enquireif their companywouldbe able to make a donationto the Societyor one to help support the
AnnualCongress.Our currentTreasurer,ProfessorRob Chilcott,has now set up a scheme for individualsto donate to
theSocietyinataxefficientmanner.FurtherdetailsaredescribedintheBTSTreasurer'sreportandIwould urge
members to support BTS by personal donations.
```

```
In termsof membershipincome,fromtheresultof theExtraordinaryGeneralMeetingheldinJune2022,the Society
has raisedmembershipfees for 2023. This is the first fee increasesince 2018. The Societyhas also implementeda £20
studentadministrationfee. As describedintheTreasurer'sreport,theaccountsof theSocietyareformally examined
inordertomeetCharityCommissionrequirements.TheSocietydoeshavesomefinancialreserves,which are
maintainedwithinCharityCommissionguidelines,inordertoachievethesustainabilityoftheSocietyby enabling
operating costs to be met for a period during times of financial distress.
```

```
ThecompanydonationsandtheincreaseinmembershipfeeswillpermittheSocietytocontinuetosupport many
initiativesincludingtheAnnualCongress,SpecialitySectionwebinarsandothermeetings,NetworkforEarly Stage
Toxicologists(NEST)activities,studentscholarshipsandbursaries.Detailsofthevariousbursariesand scholarships
offered by the Society can be found on our website.
```

```
TheachievementsoftheSocietyin2022includetheestablishmentofanewwebsite,asuccessfulAnnual Congress,
SpecialitySectionactivities,productionofpublicstatementsanda projectonlookingattheskillsgapsintraining for
regulatory toxicology.
```

```
OverthelastyeartheExecutiveCommitteehasbeenworkingwithInsightstodevelopournewwebsite.Drs Fiona
Sewell and David Masonhave led this initiativeand I wouldlike to sincerelythankthem for all theirhardwork.I hope
you will all agree that new website is a great improvement over the previous version.
```

```
Page 1
```



## `British Toxicology Society(The)` 

## `President's Report for the Year Ended 31 December 2022` 

```
As alreadymentioned,the Societyhelda very successfulAnnualCongressin April2022.The Scientific Subcommittee,
chairedbyDrLesleyReeve,haveproducedanexcellentprogrammefortheApril2023Congress.Inaddition, the
ScientificSubcommitteeare activelyidentifyingsuitablevenuesfor the BTS AnnualCongress2024 and2025 meetings
in orderthatmembers can be aware well in advanceof the dates of these futuremeetings.The Societyhas a number
ofSpecialitySectionswhichcompriseRegulatoryToxicology,RiskAssessment,ClinicalandHuman Toxicology,
MechanisticandDiscoveryToxicologyandComputationalandInsilicoToxicology.AllthesefiveSpeciality Sections
havebeenveryactivein2022andhaveheldwebinarsandothermeetings.Inaddition,anewSpecialitySection on
Ecotoxicologyhasbeenestablished.DrNatalieBurdenwillchairthisnewSpecialitySection.TheSpeciality Section
webinarsandothermeetingsprovidetrainingopportunitiesforBTSmembersandcanbeusedaspartof continuing
developmentforUKRTregistration.TheyalsoprovideanopportunityforallBTSmembers(fromstudentto retired
members) to keep up to date with various aspects of toxicology.
```

```
ThePublicCommunicationsSteeringTeam,chairedbyDrPhilBotham,hascontinuedtoproduceproactive and
reactivestatementsrelatingto issuesin toxicologywhichare of interestto the generalpublic.Thereare nowover 20
publicstatementsavailableon the BTS website. The BTS has conducteda projectto understandand identifyskills  gaps
intrainingforregulatorytoxicology.Thisprojecthasbeenco-ordinatedbyDrSarahJudge(Universityof Newcastle)
supportedbyanAdvisoryPanelofexpertsacrossanumberofsectors.Thereportofthisprojectisnowavailable on
the BTS website.
```

```
BTS members shouldbe aware that the Societyis affiliatedto the journal,ToxicologyResearch.I would encourage BTS
members to submitmanuscriptsto this journal.The Societydoes receive a small donationfrom the publisherfor each
paper published in the journal by a BTS member.
```

```
As atthestartofthisreport,I mustreiteratethatI am extremelygratefultoallthosewhoserveasmemberson the
ExecutiveCommitteeanditssubcommittees,theSpecialitySectionsandtheAmbassadors.Idoencourage members
toparticipateintheSocietybybecomingmembersofBTSCommittees.VacanciesforBTScommitteesare published
regularly both in the BTS Newsfeed and on the BTS website.
```

```
WithrespecttotheExecutiveCommittee,we havebeenseekinga newGeneralSecretaryanda newTreasurer.I am
delightedthattheExecutiveCommitteehasendorsedtheapplicationofFrancesHillfortheTreasurer'sposition. A
vacancyforanordinarymemberhasalsobecomeavailableduetoaretirementandIampleasedthatthe Executive
Committeehas endorsedDr Ehi Idahosa-Taylorfor this position.The appointmentsof boththe new Treasurerand the
ordinarymemberoftheExecutiveCommitteeareofsubjecttoratificationattheAGM.FortheGeneral Secretary
position,I am mostgratefulthatProfessorShirleyPrice,whohasbeenactingGeneralSecretarysinceApril2022, has
verykindlyagreedtotakeonthisroleforthenext2yearswhileweseekanewGeneralSecretarytowork with
Professor Price and to then take over the role permanently from April 2025.
```

```
This April sees the retirementof two members of the ExecutiveCommittee,namely ProfessorRob Chilcottand Dr  John
Thompson.IshouldliketothankbothProfessorRobChilcottandDrJohnThompsonforalltheirexcellentefforts in
helpingthe Societyachieveits objectives.In the case of ProfessorChilcott,Robhasvery kindlyagreedto shadow the
new BTS Treasurer over the coming year.
```

```
I do hopethat2023 will be a successfulyear for the SocietyandI wouldencourageall BTS members (fromstudent to
retired members) to become more involved in Society activities.
```

```
Professor Brian G. Lake
President of The British Toxicology Society
17th February 2023
```

```
Page 2
```



```
British Toxicology Society(The)
```

## `Report of the Trustees for the Year Ended 31 December 2022` 

```
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,presenttheir report
withthefinancialstatementsofthecharityfortheyearended31December2022.Thetrusteeshaveadopted the
provisionsofAccountingandReportingbyCharities:StatementofRecommendedPracticeapplicableto charities
preparingtheiraccountsinaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublic of
Ireland (FRS 102) (effective 1 January 2019).
```

## **`OBJECTIVES AND ACTIVITIES`** 

## **`Objectives and significant activities`** 

```
TheSocietyisestablishedforthepromotionandadvancement,forthepublicbenefit,ofeducationinthescience of
toxicology.In decidingthe aims and activitiesof the society,the trusteeshave paiddue regardto the guidance issued
by the CharityCommissionon publicbenefit.Toxicologyis the scienceof diseaseinducedby chemicalspresentin the
diet,medicines,andintheenvironment.TheBritishToxicologySociety(BTS)isaleadinginternational toxicology
society,basedonthehighestqualityscience,andpromotestheadvancement,communicationandunderstanding of
the scientific disciplines necessary to foster public health and environmental safety.
```

## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** 

## **`Governing document`** 

```
The Societyis a companylimitedby guaranteeandthe liabilityof members is limitedto an amountnot exceeding £1.
ItisexemptunderSection60oftheCompaniesAct2006fromtherequirementtousetheword'Limited'inits title.
TheSocietyisgovernedbytheMemorandumandArticlesofAssociation.Itisregisteredwiththe Charities
Commission, number 286197, and no liability to taxation arises.
```

```
TheExecutiveCommitteeareDirectorsforthepurposeofcompanylawandTrusteesforthepurposeofcharity law.
Directors/TrusteesareappointedbytheSociety'smembersattheAnnualGeneralMeeting.WhenaTrustee retires,
theExecutiveCommitteenominatesnewTrustees.Additionalnominationsmaybemadebythe membership,
provided they are signed by six members of the Society.
```

```
InformalinductionproceduresareinplacefornewTrustees,conductedbyanexistingmemberofthe Executive
Committeeandtheyarealsoprovidedwithrelevantdocumentationtoformallyadviseandinformthemof the
Society's constitution and objectives and also their duties and responsibilities as a trustee.
```

```
OnethirdoftheExecutiveCommitteeordinarymembersretireeachyearinrotationbutaretheneligible for
re-election.ThesocietyisorganisedsothattheTrustees,intheformoftheExecutiveCommittee,meet regularly,
usuallyonaquarterlybasis,tomanageitsaffairs.Therearealsosub-committeeswhichareresponsiblefor advising
and researching the various activities and development of the Society, who report to the Executive Committee.
```

```
Statutesfor the workingsof the varioussub-committeesare continuallybeingrevisedand updatedto ensurethat the
termsofreferenceareclearlydefinedandthewaysofworkingareconsistent.Thisalsoenablestransparency of
committeeelectionsanddurationof membership,whileallowingthecommitteestoworkto agreedaims,backed up
by comprehensive set of Standard Operating Procedures for the Society.
```

```
ThetrusteeshaveassessedthemajorriskstowhichtheSocietyisexposed,inparticularthoserelatedto the
operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks.
All of the officers and members who serve on the Society'scommitteesare unpaid.They are entitledto be reimbursed
for any out of pocket expenses incurred in attending meetings.
```

```
Norelatedparties,relatedpartytransactions,beneficialrelationshipsorconflictsofinterestrequiringdisclosure by
the Charities' or Companies' Acts existed during the year.
```

```
AttendancebyExecutiveCommitteemembershasbeenreasonablethroughouttheyear.Theco-opted members
continue to provide liaison with the relevant Sub-Committees and Speciality Sections.
```

```
The day to day administration of the Society is undertaken by an outside agency on a fee basis.
```

## **`REFERENCE AND ADMINISTRATIVE DETAILS`** 

## **`Registered Company number`** 

```
01676618 (England and Wales)
```

## **`Registered Charity number`** 

```
286197
```

```
Page 3
```



```
British Toxicology Society(The)
```

## `Report of the Trustees for the Year Ended 31 December 2022` 

## **`Registered office`** 

```
Executive Business Support Limited
City Wharf
Davidson Road
Lichfield
Staffordshire
WS14 9DZ
```

## **`Trustees`** 

```
Dr J Gill Reader In Molecular Therapeutics (resigned 4/4/2022)
Professor B G Lake Toxicologist
Dr E Marczylo Toxicologist
Dr D R Mason Toxicological Safety
Dr J Mehta Toxicologist (resigned 4/4/2022)
Dr C J Powell Histopathologist (resigned 4/4/2022)
Professor S C Price Professor Of Toxicology
Dr J Thompson Physician
Dr F Sewell Programme Manager
Dr P A Botham Toxicologist
Dr L M Reeve Toxicologist
Dr C Courage (resigned 4/4/2022)
Prof. R Chilcott
Dr I Copple Senior Lecturer in Pharmacology (appointed 4/4/2022)
Dr B Ross Senior Consultant Toxicologist (appointed 4/4/2022)
Dr H Matar Associate Professor of Toxicology (appointed 4/4/2022)
```

## **`Company Secretary`** 

```
Professor S C Price
```

## **`Independent Examiner`** 

```
Jonathon Dickens ACA
Sutton McGrath Hartley
5 Westbrook Court
Sharrowvale Road
Sheffield
South Yorkshire
S11 8YZ
```

3rd May 2023 `Approved by order of the board of trustees on ............................................. and signed on its behalf by:` 


```
........................................................................
Prof. R Chilcott - Trustee
```

```
Page 4
```



```
Independent Examiner's Report to the Trustees of
British Toxicology Society(The)
```

## **`Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')`** 

```
IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended
31 December 2022.
```

## **`Responsibilities and basis of report`** 

```
As the charity'strusteesof the Company(andalsoits directorsfor the purposesof companylaw) youare responsible
for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
```

```
Having satisfiedmyself that the accountsof the Companyare not requiredto be auditedunder Part 16 of the 2006  Act
andareeligibleforindependentexamination,Ireportinrespectofmyexaminationofyourcharity'saccounts as
carriedoutunderSection145oftheCharitiesAct2011('the2011Act').IncarryingoutmyexaminationI have
followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
```

## **`Independent examiner's statement`** 

```
Ihavecompletedmyexamination.Iconfirmthatnomattershavecometomyattentioninconnectionwith the
examination giving me cause to believe:
```

`1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or` 

`3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or` 

`4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).` 

```
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationtowhich attention
should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
```

```
Jonathon Dickens ACA
```

```
Sutton McGrath Hartley
5 Westbrook Court
Sharrowvale Road
Sheffield
South Yorkshire
S11 8YZ
```

```
Date: .............................................
```

```
Page 5
```



## `British Toxicology Society(The)` 

## `Statement of Financial Activities` 

## `for the Year Ended 31 December 2022` 

|`Unrestricted`<br>`fund`<br>`Notes`<br>`£`<br>**`INCOME AND ENDOWMENTS FROM`**<br>`Donations and legacies`<br>**`65,250`**<br>**`Charitable activities`**<br>`Annual Congress`<br>**`88,325`**<br>`Annual Congress trade exhibition`<br>**`360`**<br>`PATDD, ACT joint meetings, webinars and online`<br>`events`<br>**`15,080`**<br>`Other trading activities`<br>`2`<br>**`8,561`**<br>`Investment income`<br>`3`<br>**`812`**<br>**`Total`**<br>**`178,388`**<br>**`EXPENDITURE ON`**<br>`Raising funds`<br>`4`<br>**`30,779`**<br>**`Charitable activities`**<br>`5`<br>`Annual Congress`<br>**`91,745`**<br>`Annual Congress trade exhibition`<br>**`7`**<br>`PATDD, ACT joint meetings, webinars and online`<br>`events`<br>**`26,421`**<br>`Donations and subscriptions to other societies`<br>**`7,455`**<br>`Travel bursaries and early career support`<br>**`4,210`**<br>`Other`<br>**`23,848`**<br>**`Total`**<br>**`184,465`**<br>**`NET INCOME/(EXPENDITURE)`**<br>**`(6,077)`**<br>**`RECONCILIATION OF FUNDS`**<br>`Total funds brought forward`<br>**`379,491`**<br>**`TOTAL FUNDS CARRIED FORWARD`**<br>**`373,414`**|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`31`**<br>**`31`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`31`**<br>**`9,983`**<br>**`10,014`**|**`2022`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`65,250`**<br>**`88,325`**<br>**`360`**<br>**`15,080`**<br>**`8,561`**<br>**`843`**<br>**`178,419`**<br>**`30,779`**<br>**`91,745`**<br>**`7`**<br>**`26,421`**<br>**`7,455`**<br>**`4,210`**<br>**`23,848`**<br>**`184,465`**<br>**`(6,046)`**<br>**`389,474`**<br>**`383,428`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`65,654`<br>`25,564`<br>`3,375`<br>`20,278`<br>`9,890`<br>`1,545`|
|---|---|---|---|
||||`126,306`|
||||`29,290`<br>`11,680`<br>`-`<br>`22,286`<br>`6,607`<br>`3,124`<br>`18,871`|
||||`91,858`|
||||`34,448`<br>`355,026`|
||||`389,474`|



```
The notes form part of these financial statements
```

```
Page 6
```



## `British Toxicology Society(The)` 

## `Balance Sheet` 

## `31 December 2022` 

|`Unrestricted`<br>`fund`<br>`Notes`<br>`£`<br>**`CURRENT ASSETS`**<br>`Debtors`<br>`9`<br>**`27,163`**<br>`Cash at bank`<br>**`358,961`**<br>**`386,124`**<br>**`CREDITORS`**<br>`Amounts falling due within one year`<br>`10`<br>**`(12,710)`**<br>**`NET CURRENT ASSETS`**<br>**`373,414`**<br>**`TOTAL ASSETS LESS CURRENT LIABILITIES`**<br>**`373,414`**<br>**`NET ASSETS`**<br>**`373,414`**<br>**`FUNDS`**<br>`11`<br>`Unrestricted funds`<br>`Restricted funds`<br>**`TOTAL FUNDS`**|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`10,014`**<br>**`10,014`**<br>**`-`**<br>**`10,014`**<br>**`10,014`**<br>**`10,014`**|**`2022`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`27,163`**<br>**`368,975`**<br>**`396,138`**<br>**`(12,710)`**<br>**`383,428`**<br>**`383,428`**<br>**`383,428`**<br>**`373,414`**<br>**`10,014`**<br>**`383,428`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`28,370`<br>`378,578`<br>`406,948`<br>`(17,474)`<br>`389,474`<br>`389,474`<br>`389,474`<br>`379,491`<br>`9,983`<br>`389,474`|
|---|---|---|---|



```
The charitablecompanyis entitledto exemptionfrom audit under Section477 of the CompaniesAct 2006 for the year
ended 31 December 2022.
```

```
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended
31 December 2022 in accordance with Section 476 of the Companies Act 2006.
```

```
The trustees acknowledge their responsibilities for
```

- `(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and` 

- `(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.` 

```
The notes form part of these financial statements
```

```
continued...
```

```
Page 7
```



```
British Toxicology Society(The)
```

## `Balance Sheet - continued 31 December 2022` 

```
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicabletocharitable companies
subject to the small companies regime.
```

`The financial statements were approved by the Board of Trustees and authorised for issue on` 3rd May 2023 `............................................. and were signed on its behalf by:` 


```
.............................................
R Chilcott - Trustee
.............................................
S C Price - Trustee
```

```
The notes form part of these financial statements
```

```
Page 8
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements` 

```
for the Year Ended 31 December 2022
```

## **`1. ACCOUNTING POLICIES`** 

## **`Basis of preparing the financial statements`** 

```
The financialstatementsof the charitablecompany,whichis a publicbenefitentityunderFRS 102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingbyCharities: Statement
ofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
ReportingStandardapplicablein the UK and Republicof Ireland(FRS 102) (effective1 January2019)', Financial
ReportingStandard102 'The FinancialReportingStandardapplicablein the UK and Republicof Ireland'and the
Companies Act 2006. The financial statements have been prepared under the historical cost convention.
```

## **`Going concern`** 

```
There are no material uncertainties about the charity's ability to continue.
Thetrustees'assessmentoftherisksassociatedwithBrexitandthepandemicaredetailedinthe President's
report.
```

## **`Financial reporting standard 102 - reduced disclosure exemptions`** 

```
Thecharitablecompanyhastakenadvantageofthefollowingdisclosureexemptionsinpreparing these
financialstatements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUK and
Republic of Ireland':
```

- `the requirements of Section 7 Statement of Cash Flows;` 

- `the requirement of paragraph 3.17(d);` 

- `the requirements of  paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);` 

- `the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;` 

- `the requirement of paragraph 33.7.` 

## **`Income`** 

```
All incomingresourcesare includedin the statementof financialactivitieswhen entitlementhas passedto  the
charity;itisprobablethattheeconomicbenefitsassociatedwiththetransactionwillflowtothecharity and
theamountcanbereliablymeasured.Thefollowingspecificpoliciesareappliedtoparticularcategories of
income:
```

```
-Incomefromdonationsorgrantsisrecognisedwhenthereisevidenceofentitlementtothegift,receipt is
probable and its amount can be measured reliably.
```

```
- Legacy income is recognised when receipt is probable and entitlement is established.
```

```
- Incomefromdonatedgoodsismeasuredatthefairvalueofthegoodsunlessthisisimpracticalto measure
reliably,inwhichcasethevalueis derivedfromthecosttothedonorortheestimatedresalevalue. Donated
facilitiesandservicesarerecognisedintheaccountswhenreceivedifthevaluecanbereliablymeasured. No
amounts are included for the contribution of general volunteers.
```

```
- Income from contractsfor the supplyof services is recognisedwith the delivery of the contractedservice. This
isclassifiedasunrestrictedfundsunlessthereisacontractualrequirementforittobespentona particular
purpose and returned if unspent, in which case it may be regarded as restricted.
```

## **`Expenditure`** 

```
Expenditureisrecognisedonanaccrualsbasisasaliabilityisincurred.ExpenditureincludesanyVAT which
cannotbefullyrecovered,andisclassifiedunderheadingsofthestatementoffinancialactivitiestowhich it
relates:
```

```
-Expenditureonraisingfundsincludesthecostsofallfundraisingactivities,events,non-charitable trading
activities, and the sale of donated goods.
```

```
continued...
```

```
Page 9
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued` 

## `for the Year Ended 31 December 2022` 

## **`1. ACCOUNTING POLICIES - continued`** 

## **`Expenditure`** 

```
-Expenditureoncharitableactivitiesincludesallcostsincurredbyacharityinundertakingactivities that
furtherits charitableaims for the benefit of its beneficiaries,includingthose supportcosts and costs relating to
the governance of the charity apportioned to charitable activities.
```

```
- Otherexpenditureincludesallexpenditurethatisneitherrelatedtoraisingfundsforthecharitynorpart of
its expenditure on charitable activities.
```

```
All costsare allocatedto expenditurecategoriesreflectingthe use of the resource.Directcostsattributable to
a singleactivityare allocateddirectlyto that activity.Sharedcosts are apportionedbetweenthe activities they
contribute to on a reasonable, justifiable and consistent basis.
```

## **`Taxation`** 

```
The charity is exempt from corporation tax on its charitable activities.
```

## **`Fund accounting`** 

```
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
```

```
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity.
Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
```

```
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
```

## **`2. OTHER TRADING ACTIVITIES`** 

|**`OTHER TRADING ACTIVITIES`**|||||
|---|---|---|---|---|
||||**`2022`**|`2021`|
||`Unrestricted`|`Restricted`|**`Total`**|`Total`|
||`funds`|`funds`|**`funds`**|`funds`|
||`£`|`£`|**`£`**|`£`|
|`Website advertising`|**`6,901`**|**`-`**|**`6,901`**|`8,150`|
|`OUP / RSC Journal income`|**`1,660`**|**`-`**|**`1,660`**|`1,740`|
||**`8,561`**|**`-`**|**`8,561`**|`9,890`|



## **`3. INVESTMENT INCOME`** 

|**`INVESTMENT INCOME`**|||||
|---|---|---|---|---|
||||**`2022`**|`2021`|
||`Unrestricted`|`Restricted`|**`Total`**|`Total`|
||`funds`|`funds`|**`funds`**|`funds`|
||`£`|`£`|**`£`**|`£`|
|`Deposit account interest`|**`812`**|**`31`**|**`843`**|`1,545`|



```
continued...
```

```
Page 10
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued` 

## `for the Year Ended 31 December 2022` 

## **`4. RAISING FUNDS`** 

## **`Raising donations and legacies`** 

|**`Raising donations and legacies`**|||
|---|---|---|
|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>`Bank charges`<br>**`817`**<br>**`-`**<br>`EBS - membership processing`<br>**`11,176`**<br>**`-`**<br>`Support costs`<br>**`7,391`**<br>**`-`**<br>**`19,384`**<br>**`-`**|**`2022`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`817`**<br>**`11,176`**<br>**`7,391`**<br>**`19,384`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`852`<br>`10,512`<br>`3,516`|
|||`14,880`|



## **`Other trading activities`** 

|`Unrestricted`<br>`funds`<br>`£`<br>`EBS- website management`<br>**`9,134`**<br>`ACT webinars`<br>**`662`**<br>`AIT webinars`<br>**`1,000`**<br>`Bank charges`<br>**`56`**<br>`Publicity materials`<br>**`-`**<br>`Ambassadors scheme`<br>**`543`**<br>`Support costs`<br>**`-`**<br>**`11,395`**<br>`Aggregate amounts`<br>**`30,779`**<br>**`5.`**<br>**`CHARITABLE ACTIVITIES COSTS`**<br>`Annual Congress`<br>`Annual Congress trade exhibition`<br>`PATDD, ACT joint meetings, webinars`<br>`and online events`<br>`Donations and subscriptions to other`<br>`societies`<br>`Travel bursaries and early career`<br>`support`|`Restricted`<br>`funds`<br>`£`<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>`Direct`<br>`Costs`<br>`£`<br>**`91,275`**<br>**`7`**<br>**`1,421`**<br>**`5,724`**<br>**`4,210`**<br>**`102,637`**|**`2022`**<br>**`Total`**<br>**`funds`**<br>**`£`**<br>**`9,134`**<br>**`662`**<br>**`1,000`**<br>**`56`**<br>**`-`**<br>**`543`**<br>**`-`**<br>**`11,395`**<br>**`30,779`**<br>`Support`<br>`costs (see`<br>`note 6)`<br>`£`<br>**`470`**<br>**`-`**<br>**`25,000`**<br>**`1,731`**<br>**`-`**<br>**`27,201`**||`2021`<br>`Total`<br>`funds`<br>`£`<br>`9,426`<br>`805`<br>`-`<br>`61`<br>`600`<br>`-`<br>`3,518`|
|---|---|---|---|---|
|||||`14,410`|
|||||`29,290`|
|||||`Totals`<br>`£`<br>**`91,745`**<br>**`7`**<br>**`26,421`**<br>**`7,455`**<br>**`4,210`**|
||||**`129,838`**||



```
continued...
```

```
Page 11
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued for the Year Ended 31 December 2022` 

## **`6. SUPPORT COSTS`** 

|`Management`<br>`£`<br>`Raising donations and`<br>`legacies`<br>**`-`**<br>`Other resources expended`<br>**`8,099`**<br>`Annual Congress`<br>**`470`**<br>`PATDD, ACT joint meetings,`<br>`webinars and online events`<br>**`-`**<br>`Donations and`<br>`subscriptions to other`<br>`societies`<br>**`-`**<br>**`8,569`**|`Information`<br>`Governance`<br>`Finance`<br>`technology`<br>`costs`<br>`£`<br>`£`<br>`£`<br>**`7,391`**<br>**`-`**<br>**`-`**<br>**`6,160`**<br>**`3,801`**<br>**`5,788`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`-`**<br>**`25,000`**<br>**`1,231`**<br>**`500`**<br>**`-`**<br>**`14,782`**<br>**`4,301`**<br>**`30,788`**|`Totals`<br>`£`<br>**`7,391`**<br>**`23,848`**<br>**`470`**<br>**`25,000`**<br>**`1,731`**|
|---|---|---|
|||**`58,440`**|



## **`7. TRUSTEES' REMUNERATION AND BENEFITS`** 

```
There were no trustees'remunerationor other benefitsfor the year ended 31 December 2022 nor for the year
ended 31 December 2021.
```

## **`Trustees' expenses`** 

|**`Trustees' expenses`**||||
|---|---|---|---|
|`Trustees' expenses`<br>**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**<br>`Unrestricted`<br>`fund`<br>`£`<br>**`INCOME AND ENDOWMENTS FROM`**<br>`Donations and legacies`<br>`65,654`<br>**`Charitable activities`**<br>`Annual Congress`<br>`25,564`<br>`Annual Congress trade exhibition`<br>`3,375`<br>`PATDD, ACT joint meetings, webinars and`<br>`online events`<br>`20,278`<br>`Other trading activities`<br>`9,890`<br>`Investment income`<br>`1,524`<br>**`Total`**<br>`126,285`<br>**`EXPENDITURE ON`**<br>`Raising funds`<br>`29,290`<br>**`Charitable activities`**<br>`Annual Congress`<br>`11,680`<br>`PATDD, ACT joint meetings, webinars and`<br>`online events`<br>`22,286`<br>`Donations and subscriptions to other`<br>`societies`<br>`6,607`|**`2022`**<br>**`£`**<br>**`540`**<br>`Restricted`<br>`funds`<br>`£`<br>`-`<br>`-`<br>`-`<br>`-`<br>`-`<br>`21`<br>`21`<br>`-`<br>`-`<br>`-`<br>`-`|`2021`<br>`£`<br>`426`<br>`Total`<br>`funds`<br>`£`<br>`65,654`<br>`25,564`<br>`3,375`<br>`20,278`<br>`9,890`<br>`1,545`||
||||`126,306`|
||||`29,290`<br>`11,680`<br>`22,286`<br>`6,607`|



## **`8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`** 

```
continued...
```

```
Page 12
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued for the Year Ended 31 December 2022` 

|**`8.`**<br>**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued`**<br>`Unrestricted`<br>`fund`<br>`£`<br>`Travel bursaries and early career support`<br>`3,124`<br>`Other`<br>`18,871`<br>**`Total`**<br>`91,858`<br>**`NET INCOME`**<br>`34,427`<br>**`RECONCILIATION OF FUNDS`**<br>`Total funds brought forward`<br>`345,064`<br>**`TOTAL FUNDS CARRIED FORWARD`**<br>`379,491`<br>**`9.`**<br>**`DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**<br>`Debtors`<br>`Prepayments & accrued income`<br>**`10.`**<br>**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**<br>`Trade creditors`<br>`Accruals & prepaid income`<br>**`11.`**<br>**`MOVEMENT IN FUNDS`**<br>`At 1/1/22`<br>`£`<br>**`Unrestricted funds`**<br>`General fund`<br>**`379,491`**<br>**`Restricted funds`**<br>`Barnes fund`<br>**`812`**<br>`Paton fund`<br>**`3,770`**<br>`Norman Aldridge fund`<br>**`5,401`**<br>**`9,983`**<br>**`TOTAL FUNDS`**<br>**`389,474`**|`Restricted`<br>`funds`<br>`£`<br>`-`<br>`-`<br>`-`<br>`21`<br>`9,962`<br>`9,983`<br>**`2022`**<br>**`£`**<br>**`3,014`**<br>**`24,149`**<br>**`27,163`**<br>**`2022`**<br>**`£`**<br>**`4,689`**<br>**`8,021`**<br>**`12,710`**<br>`Net`<br>`movement`<br>`in funds`<br>`£`<br>**`(6,077)`**<br>**`1`**<br>**`7`**<br>**`23`**<br>**`31`**<br>**`(6,046)`**|`Total`<br>`funds`<br>`£`<br>`3,124`<br>`18,871`<br>`91,858`<br>`34,448`<br>`355,026`<br>`389,474`<br>`2021`<br>`£`<br>`5,540`<br>`22,830`<br>`28,370`<br>`2021`<br>`£`<br>`4,365`<br>`13,109`<br>`17,474`<br>`At`<br>`31/12/22`<br>`£`<br>**`373,414`**<br>**`813`**<br>**`3,777`**<br>**`5,424`**<br>**`10,014`**<br>**`383,428`**|`Total`<br>`funds`<br>`£`<br>`3,124`<br>`18,871`|
|---|---|---|---|
||||`91,858`|
||||`34,448`<br>`355,026`|
||||`389,474`|



```
continued...
```

```
Page 13
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued` 

## `for the Year Ended 31 December 2022` 

## **`11. MOVEMENT IN FUNDS - continued`** 

```
Net movement in funds, included in the above are as follows:
```

|**`Unrestricted funds`**<br>`General fund`<br>**`Restricted funds`**<br>`Barnes fund`<br>`Paton fund`<br>`Norman Aldridge fund`<br>**`TOTAL FUNDS`**<br>**`Comparatives for movement in funds`**<br>**`Unrestricted funds`**<br>`General fund`<br>**`Restricted funds`**<br>`Barnes fund`<br>`Paton fund`<br>`Norman Aldridge fund`<br>**`TOTAL FUNDS`**|`Incoming`<br>`resources`<br>`£`<br>**`178,388`**<br>**`1`**<br>**`7`**<br>**`23`**<br>**`31`**<br>**`178,419`**<br>`At 1/1/21`<br>`£`<br>`345,064`<br>`811`<br>`3,768`<br>`5,383`<br>`9,962`<br>`355,026`|`Resources`<br>`Movement`<br>`expended`<br>`in funds`<br>`£`<br>`£`<br>**`(184,465)`**<br>**`(6,077)`**<br>**`-`**<br>**`1`**<br>**`-`**<br>**`7`**<br>**`-`**<br>**`23`**<br>**`-`**<br>**`31`**<br>**`(184,465)`**<br>**`(6,046)`**<br>`Net`<br>`movement`<br>`At`<br>`in funds`<br>`31/12/21`<br>`£`<br>`£`<br>`34,427`<br>`379,491`<br>`1`<br>`812`<br>`2`<br>`3,770`<br>`18`<br>`5,401`<br>`21`<br>`9,983`<br>`34,448`<br>`389,474`|
|---|---|---|



```
continued...
```

```
Page 14
```



```
British Toxicology Society(The)
```

## `Notes to the Financial Statements - continued` 

## `for the Year Ended 31 December 2022` 

## **`11. MOVEMENT IN FUNDS - continued`** 

```
Comparative net movement in funds, included in the above are as follows:
```

|**`Unrestricted funds`**<br>`General fund`<br>**`Restricted funds`**<br>`Barnes fund`<br>`Paton fund`<br>`Norman Aldridge fund`<br>**`TOTAL FUNDS`**|`Incoming`<br>`resources`<br>`£`<br>`126,285`<br>`1`<br>`2`<br>`18`<br>`21`<br>`126,306`|`Resources`<br>`Movement`<br>`expended`<br>`in funds`<br>`£`<br>`£`<br>`(91,858)`<br>`34,427`<br>`-`<br>`1`<br>`-`<br>`2`<br>`-`<br>`18`<br>`-`<br>`21`<br>`(91,858)`<br>`34,448`|
|---|---|---|



```
Restrictedfundscomprisedonationsgiven to providelectureawards,travelgrantsand supportto early career
toxicologists. Awards are made by the trustees on an alternate year basis.
```

## **`12. RELATED PARTY DISCLOSURES`** 

```
There were no related party transactions.
```

```
Page 15
```



```
British Toxicology Society(The)
```

## `Detailed Statement of Financial Activities` 

## `for the Year Ended 31 December 2022` 

|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`INCOME AND ENDOWMENTS`**<br>**`Donations and legacies`**<br>`Donations`<br>**`10,050`**<br>**`-`**<br>`Subscriptions`<br>**`55,200`**<br>**`-`**<br>**`65,250`**<br>**`-`**<br>**`Other trading activities`**<br>`Website advertising`<br>**`6,901`**<br>**`-`**<br>`OUP / RSC Journal income`<br>**`1,660`**<br>**`-`**<br>**`8,561`**<br>**`-`**<br>**`Investment income`**<br>`Deposit account interest`<br>**`812`**<br>**`31`**<br>**`Charitable activities`**<br>`Annual Congress delegates`<br>**`84,425`**<br>**`-`**<br>`Annual Congress donations`<br>**`3,900`**<br>**`-`**<br>`Annual Congress exhibitors and trade stands`<br>**`360`**<br>**`-`**<br>`PATDD & ACT joint meetings & webinars`<br>**`15,080`**<br>**`-`**<br>**`103,765`**<br>**`-`**<br>**`Total incoming resources`**<br>**`178,388`**<br>**`31`**<br>**`EXPENDITURE`**<br>**`Raising donations and legacies`**<br>`Bank charges`<br>**`817`**<br>**`-`**<br>`EBS - membership processing`<br>**`11,176`**<br>**`-`**<br>**`11,993`**<br>**`-`**<br>**`Other trading activities`**<br>`EBS- website management`<br>**`9,134`**<br>**`-`**<br>`ACT webinars`<br>**`662`**<br>**`-`**<br>`AIT webinars`<br>**`1,000`**<br>**`-`**<br>`Bank charges`<br>**`56`**<br>**`-`**<br>`Publicity materials`<br>**`-`**<br>**`-`**<br>`Ambassadors scheme`<br>**`543`**<br>**`-`**<br>**`11,395`**<br>**`-`**|`2022`<br>`Total`<br>`funds`<br>`£`<br>**`10,050`**<br>**`55,200`**<br>**`65,250`**<br>**`6,901`**<br>**`1,660`**<br>**`8,561`**<br>**`843`**<br>**`84,425`**<br>**`3,900`**<br>**`360`**<br>**`15,080`**<br>**`103,765`**<br>**`178,419`**<br>**`817`**<br>**`11,176`**<br>**`11,993`**<br>**`9,134`**<br>**`662`**<br>**`1,000`**<br>**`56`**<br>**`-`**<br>**`543`**<br>**`11,395`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`11,250`<br>`54,404`|
|---|---|---|
|||`65,654`<br>`8,150`<br>`1,740`|
|||`9,890`<br>`1,545`<br>`20,665`<br>`4,899`<br>`3,375`<br>`20,278`|
|||`49,217`|
|||`126,306`<br>`852`<br>`10,512`|
|||`11,364`<br>`9,426`<br>`805`<br>`-`<br>`61`<br>`600`<br>`-`|
|||`10,892`|



```
This page does not form part of the statutory financial statements
```

```
Page 16
```



## `British Toxicology Society(The)` 

## `Detailed Statement of Financial Activities for the Year Ended 31 December 2022` 

|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`Other trading activities`**<br>**`Charitable activities`**<br>`Publicity`<br>**`-`**<br>**`-`**<br>`Insurance`<br>**`908`**<br>**`-`**<br>`Entertainment`<br>**`1,188`**<br>**`-`**<br>`Security`<br>**`880`**<br>**`-`**<br>`Speakers' expenses`<br>**`1,439`**<br>**`-`**<br>`Delegate materials`<br>**`226`**<br>**`-`**<br>`Accommodation and meals`<br>**`61,873`**<br>**`-`**<br>`Technicians and equipment hire`<br>**`11,928`**<br>**`-`**<br>`Bank charges`<br>**`68`**<br>**`-`**<br>`EBS management fee`<br>**`10,832`**<br>**`-`**<br>`EBS travel expenses`<br>**`456`**<br>**`-`**<br>`EBS processing fees`<br>**`2,456`**<br>**`-`**<br>`Eurotox subscription`<br>**`1,668`**<br>**`-`**<br>`Understanding Animal Research`<br>**`277`**<br>**`-`**<br>`Society of Biology`<br>**`690`**<br>**`-`**<br>`Iutox International`<br>**`3,059`**<br>**`-`**<br>`Science workshops`<br>**`-`**<br>**`-`**<br>`Early career prizes`<br>**`777`**<br>**`-`**<br>`Travel bursary`<br>**`1,690`**<br>**`-`**<br>`Studentship`<br>**`-`**<br>**`-`**<br>`Oral presentation prize`<br>**`200`**<br>**`-`**<br>`Recognition awards`<br>**`-`**<br>**`-`**<br>`Poster presentation prize`<br>**`300`**<br>**`-`**<br>`NEST promotional materials`<br>**`1,722`**<br>**`-`**<br>**`102,637`**<br>**`-`**<br>**`Support costs`**<br>**`Management`**<br>`Postage and stationery`<br>**`635`**<br>**`-`**<br>`EBS- trustee support`<br>**`7,934`**<br>**`-`**<br>**`8,569`**<br>**`-`**<br>**`Finance`**<br>`EBS- bookkeeping & finance`<br>**`14,782`**<br>**`-`**<br>**`Information technology`**<br>`EBS- licences & IT support`<br>**`3,801`**<br>**`-`**<br>`EDIS membership contribution`<br>**`500`**<br>**`-`**<br>**`4,301`**<br>**`-`**<br>**`Governance costs`**<br>`Meeting expenses - trustees`<br>**`540`**<br>**`-`**<br>`Carried forward`<br>**`540`**<br>**`-`**|`2022`<br>`Total`<br>`funds`<br>`£`<br>**`-`**<br>**`908`**<br>**`1,188`**<br>**`880`**<br>**`1,439`**<br>**`226`**<br>**`61,873`**<br>**`11,928`**<br>**`68`**<br>**`10,832`**<br>**`456`**<br>**`2,456`**<br>**`1,668`**<br>**`277`**<br>**`690`**<br>**`3,059`**<br>**`-`**<br>**`777`**<br>**`1,690`**<br>**`-`**<br>**`200`**<br>**`-`**<br>**`300`**<br>**`1,722`**<br>**`102,637`**<br>**`635`**<br>**`7,934`**<br>**`8,569`**<br>**`14,782`**<br>**`3,801`**<br>**`500`**<br>**`4,301`**<br>**`540`**<br>**`540`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`19`<br>`-`<br>`30`<br>`-`<br>`2,068`<br>`-`<br>`-`<br>`-`<br>`37`<br>`25,034`<br>`-`<br>`1,516`<br>`1,690`<br>`266`<br>`690`<br>`2,759`<br>`600`<br>`420`<br>`-`<br>`1,208`<br>`100`<br>`224`<br>`-`<br>`-`|
|---|---|---|
|||`36,661`<br>`269`<br>`7,554`|
|||`7,823`<br>`14,070`<br>`3,491`<br>`-`|
|||`3,491`<br>`426`<br>`426`|



```
This page does not form part of the statutory financial statements
```

```
Page 17
```



```
British Toxicology Society(The)
```

## `Detailed Statement of Financial Activities for the Year Ended 31 December 2022` 

|`Detailed Statement of Financial Activities`<br>`for the Year Ended 31 December 2022`|||
|---|---|---|
|`Unrestricted`<br>`Restricted`<br>`funds`<br>`funds`<br>`£`<br>`£`<br>**`Governance costs`**<br>`Brought forward`<br>**`540`**<br>**`-`**<br>`Accountancy fees`<br>**`5,248`**<br>**`-`**<br>`Company secretarial and AGM`<br>**`-`**<br>**`-`**<br>`Meeting expenses- non trustees`<br>**`-`**<br>**`-`**<br>`Project co-ordinator`<br>**`25,000`**<br>**`-`**<br>**`30,788`**<br>**`-`**<br>`Total resources expended`<br>**`184,465`**<br>**`-`**<br>**`Net income`**<br>**`(6,077)`**<br>**`31`**|`2022`<br>`Total`<br>`funds`<br>`£`<br>**`540`**<br>**`5,248`**<br>**`-`**<br>**`-`**<br>**`25,000`**<br>**`30,788`**<br>**`184,465`**<br>**`(6,046)`**|`2021`<br>`Total`<br>`funds`<br>`£`<br>`426`<br>`7,026`<br>`13`<br>`92`<br>`-`|
|||`7,557`|
|||`91,858`|
|||`34,448`|



```
This page does not form part of the statutory financial statements
```

```
Page 18
```

